Difficulty: Medium
Average Score: 93%
Practice
Pseudocholinesterase differs from cholinesterase in that
Correct answer
B
Rationale
In this question, the correct answer is B) It hydrolyzes acetylcholine at a slower rate. Pseudocholinesterase differs from cholinesterase in that it has a slower hydrolysis rate for acetylcholine. This is a crucial distinction because cholinesterase is found primarily in the synaptic cleft where it rapidly breaks down acetylcholine, while pseudocholinesterase is found in the plasma and has a slower rate of acetylcholine hydrolysis.
Option A) It does not hydrolyze acetylcholine is incorrect because pseudocholinesterase does hydrolyze acetylcholine, albeit at a slower rate than cholinesterase. Option C) It is more susceptible to inhibition by physostigmine is incorrect as physostigmine primarily inhibits acetylcholinesterase, not pseudocholinesterase. Option D) It is the only form of circulating cholinesterase is incorrect as cholinesterase also circulates in the plasma.
Understanding the differences between pseudocholinesterase and cholinesterase is essential in pharmacology, especially when considering drugs that target these enzymes. Having a clear grasp of these distinctions can help healthcare professionals make informed decisions when managing patients receiving medications that affect cholinergic transmission in the central nervous system.
Option A) It does not hydrolyze acetylcholine is incorrect because pseudocholinesterase does hydrolyze acetylcholine, albeit at a slower rate than cholinesterase. Option C) It is more susceptible to inhibition by physostigmine is incorrect as physostigmine primarily inhibits acetylcholinesterase, not pseudocholinesterase. Option D) It is the only form of circulating cholinesterase is incorrect as cholinesterase also circulates in the plasma.
Understanding the differences between pseudocholinesterase and cholinesterase is essential in pharmacology, especially when considering drugs that target these enzymes. Having a clear grasp of these distinctions can help healthcare professionals make informed decisions when managing patients receiving medications that affect cholinergic transmission in the central nervous system.